Apnimed
Apnimed develops oral therapies for sleep-related breathing diseases.
SCHEDULE 13GNov 16Latest SEC filing
Nov 16Latest story
November 2026
September 2026
August 2026
July 2026
Apnimed develops oral therapies for sleep-related breathing diseases.
November 2026
September 2026
August 2026
July 2026